Efgartigimod improves muscle weakness in a mouse model for muscle-specific kinase myasthenia gravis

Author(s):
Huijbers, M.G.; Plomp, J.J. (0000-0002-8427-9090); Es, I.E. van; Fillie-Grijpma, Y.E.; Kamar-Al Majidi, S.; Ulrichts, P.; Haard, H. de; Hofman, E.; Maarel, S.M. van der (0000-0001-8103-711X); Verschuuren, J.J.
Published
2019
Publication type
Article / Letter to editor
MuSKMyasthenia gravisNeonatal Fc receptorNeuroimmunologyNeuromuscular junctionNeuromuscular diseases
Date issued
2019-07-31
Language
English
Is part of
Experimental Neurology (2019), Vol. 317, p. 133-143
hdl
1887/120816
doi
10.1016/j.expneurol.2019.03.001